Our work in the pharmaceutical industry is about more than just testing—it's about helping our clients solve problems, navigate complex regulatory environments and provide them with the ability to move their business forward.
Taking the guesswork out of the equation
Unforeseen delays can add a tremendous amount of risk, both to the development of a product and the success of a company. While it’s often an unfortunate reality, it’s not always a necessary one.
At Diteba, our experience and support of both large and small molecule testing for various dosage forms—solids, semi-solids, liquids, aerosols and others—allows us to reduce program risk by eliminating delays caused by scheduling, technical and quality issues.
Translating regulatory guidance into quality science
We understand how complex the regulatory world is. That’s why we ensure the strictest compliance with the latest updates of regulatory requirements for the pharmaceutical industry. We also know how quickly needs and requirements can change. That’s why flexibility and adaptiveness remain core tenets of how we approach our work.
Our testing services are performed in accordance with the requirements of the US Food and Drug Administration (FDA), Health Canada and the International Conference on Harmonization (ICH). Diteba is licensed by Health Canada as a GMP drug establishment and registered as a drug establishment with the FDA.
What you need, when you need it
We work well under the pressure created by an increasing desire to push analytical work into later stages of drug development where our work is often the last step prior to submittal. We’re here to help no matter what stage you need us – saving you time and money while adding a little extra peace of mind can go a long way.
But don’t just take our word for it. Our doors are always open for clients to visit key quality and scientific personnel and see first-hand the quality programs, scientific expertise and facility and equipment capabilities we have.